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Abstract 
 
Background:  
Obesity is a growing global burden; current studies have projected the prevalence of obese / 
overweight individuals to increase to ~1.35 billion by 2030. A number of factors contribute to 
cardiovascular diseases, of which the focus of this study is what effect an increased level of 
free fatty acids has on the flux through the hexosamine biosynthetic pathway (HBP). It has 
been widely proven that an increased flux through the HBP causes an increase in protein O-
GlcNAcylation, which leads to increased reactive oxygen species (ROS) production as well 
as an increase in cell death (apoptosis). 
 
Methods: 
For the purpose of this study a cell model was used. H9c2 cardiomyoblasts were cultured in 
5ml Dulbecco‟s Modified Eagles Medium (DMEM) supplemented with  
10% foetal bovine serum and 1% penicillin-streptomycin. The cells were then exposed to 
0.25mM monounsaturated fatty acid (oleic acid) for 24, 48 and 72 hours respectively. The 
cultured cells were then evaluated to assess the degree ROS production, overall O-
GlcNAcylation and cell death (apoptosis and necrosis), using flow cytometry and 
immunofluorescence microscopy. 
 
Results:  
We found that oleic acid causes a significant decrease in ROS production at the  
48 hour time point when analysed on the flow cytometer, which indicates that oleic acid is 
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metabolized by the cells in a independent manner. Oleic acid also caused a significant 
decrease in cell death at all the time intervals. With regard to the HBP, oleic acid activates 
this pathway but causes downstream cardioprotective effects that do not necessarily occur 
along this pathway. 
 
Conclusion:  
This study explored whether a monounsaturated fatty acid, oleic acid, is able to act as a novel 
cardioprotective agent. The in vitro data supports this concept and we showed that it is able to 
blunt oxidative stress and cell death. It was also found that although oleic acid activated the 
HBP, it did not mediate its protective effects via this pathway only. 
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Opsomming 
 
Agtergrond:  
Vetsug is „n groeiende wêreldlas; huidige studies voorspel dat die voorkoms van vetsugtige / 
oorgewig individue toe sal neem tot ~1.35 biljoen teen 2030.  Alhoewel verskeie faktore tot 
kardiovaskulêre siektes bydra is die fokus van hierdie studie om die effek van verhoogde 
vryvetsuurvlakke op die fluks deur die heksosamienbiosintestiese weg (HBW) te ondersoek. 
Dit is reeds bewys dat verhoogde fluks deur die HBW „n verhoging in proteïen O-
GlcNAsilering lei, wat verder tot verhoogde reaktiewe suusrtofspesies (ROS) vorming 
aanleiding gee en ook seldood (apoptose) verhoog.   
 
Metodes:  
„n Selmodel is vir die doel van hierdie studie gebruik. H9c2 kardiomioblaste is in 5ml 
Dulbecco‟s Modified Eagles Medium (DMEM) gekweek en gesupplementeer met 10% fetale 
beesserum en 1% penisillien-streptomysien. Die selle is blootgestel aan „n 0.25mM mono 
onversadigde vetsuur (oleïensuur ) vir 24, 48 en 72 uur onderskeidelik. Die gekweekte selle is 
gevolglik ondersoek vir die graad van ROS ontwikkeling, algehele O-GlcNAsilering en 
seldood (apoptosis en nekrose), deur van vloeisitometrie en immunofluoresensie mikroskopie 
gebruik te maak. 
 
Resultate:  
Ons het bevind dat oleïensuur „n betekenisvolle verlaging in ROS ontwikkeling teen 48 uur 
soos bepaal deur die vloeisitometer, veroorsaak. Dit wys daarop dat oleïensuur deur die selle 
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op „n onafhanklike wyse gemetaboliseer is.  Oleïensuur het ook „n betekenisvolle verlaging in 
seldood by alle tydsintervalle veroorsaak. Met betrekking tot die HBW het oleïensuur hierdie 
weg geaktiveer maar afstroom kardiobeskermings effekte versoorsaak wat nie noodwendig 
langs hierdie weg onstaan nie.  
 
Gevolgtrekking:  
Hierdie studie het die moontlikheid van „n mono-onversadige vetsuur, oleïensuur, om op te 
tree as „n nuwe kardiobeskermingsmiddel ondersoek. Die in vitro data ondersteun hierdie 
konsep en hier is aangetoon dat dit wel oksidatiewe stres en seldood onderdruk. Daar is 
verder bevind dat alhoewel oleïensuur die HBW aktiveer dit nie die beskermings effekte 
alleenlik via hierdie weg medieer nie. 
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1.1 Epidemiology 
Obesity is a global growing burden; current studies project that the prevalence of overweight 
/ obese individuals will increase to ~1.35 billion by 2030 [45]. Epidemiological studies 
demonstrate that causes for this burden include genetics; age; gender; ethnicity; income 
brackets; poverty; urbanization; stress; lack of physical exercise and poor dietary habits [99]. 
Moreover, genetic inheritance also contributes, albeit to a lesser extent [99]. 
Urbanization is a central player in this process since populations are moving from rural to 
urban areas where they search for better employment, housing and education. This causes a 
shift in dietary patterns and lifestyle changes, thereby increasing the prevalence of health 
risks, particularly obesity and associated diseases, e.g. diabetes and cardiovascular diseases 
(CVD) [99]. 
Modern-day, western diets are typically high in carbohydrates and saturated fats [3]. The link 
between high fat intake and the onset of CVD is well established. However, high 
carbohydrate intake has recently also been identified as a major concern in this regard. For 
example, Majane et al [54] found that the consumption of high sugar diets caused a ~10% 
increase in body weight that ultimately led to hypertension and thus a pre-disposition to 
CVD. This study therefore shows that poor nutritional intake choices („junk food‟) can be 
linked to the onset of heart failure [32]. Here, excess nutrients e.g. sugars are proposed to 
trigger maladaptive signalling pathways that contribute to the onset of impaired contractile 
function. 
Thus, greater focus has been placed on improved nutritional intake and higher levels of 
exercise to help blunt the challenge of obesity and associated conditions, e.g. CVD. For 
example, altered serum cholesterol levels are now strongly linked to coronary artery disease 
Stellenbosch University http://scholar.sun.ac.za
3 
 
(CAD). In an effort to aid improved nutrition, health guidelines were set by the American 
Heart Association which are also implemented in clinical trials, i.e. Mediterranean-style Step 
I diet [45]. In similar fashion other lifestyle changes, e.g. reduced tobacco intake and/or 
increased exercise helps attenuate the growing incidence of obesity, type 2 diabetes and 
CVD. However, despite these attempts cardio-metabolic diseases continue to increase, 
especially in developing countries. For example, it is projected that the incidence of diabetes 
(~171 million in 2000) will double by 2030 [99]. Moreover, it is proposed that there is a link 
between CVD, physical inactivity and unhealthy diets which are major contributing factors. 
We face enormous challenges to manage cardio-metabolic diseases since it will result in 
marked effects in economies and overall productivity and well-being. Greater emphasis 
should therefore be placed on understanding the underlying mechanisms responsible since 
this should lead to improved therapy to treat diabetes and CVD. 
Since the focus of this thesis is on the effects of a fatty acid on the viability of heart cells, I 
will now contextualize my work by providing a brief synopsis of cardiac metabolism. 
 
1.2 Metabolism of the heart 
The mammalian heart utilizes a variety of fuel substrates to generate adequate adenosine 
triphosphate (ATP) to sustain its function. These include fatty acids, glucose, lactate and 
ketone bodies [14]. Cardiac fuel substrate utilization is a dynamic process where the heart can 
switch between glucose (fed state) and fatty acids (fasted state), as an energy source. During 
the fasted state, circulating free fatty acid levels are high and fatty acids become the main 
energy source. Post prandially, a high-fat meal leads to increased lipoprotein lipase that 
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converts triglycerides to free fatty acids (FFA) that can undergo mitochondrial fatty acid 
oxidation. 
During the fed state, when circulating glucose and insulin levels are high, fatty acid levels are 
low, with fatty acid oxidation attenuated while glucose oxidation increases. Post prandial 
hyperglycaemia following a high carbohydrate meal leads to increased plasma glucose levels 
and insulin secretion from pancreatic β-cells that ensures glucose uptake by peripheral tissues 
such as skeletal muscle and the heart [31, 86].  
Conversely, during the fasted state circulating glucose and insulin levels decrease and the 
organism enters a catabolic state. Thus, glucose uptake and metabolism decrease while 
circulating fatty acid levels rise. In parallel, fatty acid uptake increases leading to higher 
mitochondrial fatty acid oxidation rates. During exercise, lactate becomes the major energy 
source [6, 30] that results in down regulation of both glucose oxidation and fatty acid uptake. 
Finally, during starvation ketone bodies can also act as a significant energy source for the 
heart [29].  
The switch between glucose and fatty acids as fuel sources during the fed and fasted state was 
first described by Randle et al. in 1963, and is popularly known as the glucose-fatty acid 
cycle or Randle cycle. [24, 75] Randle et al. [75] describes the fuel flux between glucose and 
fatty acids and proposed that glucose utilization is decreased under conditions of high fatty 
acid oxidation. Under these conditions the heart will preferentially utilize one fuel versus the 
other. The by-products of fatty acid oxidation, i.e. NADH and acetyl-CoA inhibit the rate-
limiting step of glucose oxidation, i.e. pyruvate dehydrogenase (PDH) [76]. This leads to a 
decrease in mitochondrial glucose metabolism. Furthermore, increased citrate generated from 
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acetyl-CoA may also inhibit glycolysis and glucose uptake though inhibition of 6-
phosphofructose-1-kinase (PFK) in the glycolytic pathway.  
On the contrary, high glucose oxidation can decrease fatty acid oxidation. Increased acetyl-
CoA can be converted to malonyl-CoA a potent inhibitor of carnitine palmitoyl transferase-1 
(CPT-1), the rate-limiting enzyme responsible for mitochondrial fatty acid uptake. This 
process takes place throughout the day depending on nutritional intake and levels. A brief 
review of the major metabolic fuel substrates of the heart, i.e. glucose and fatty acid 
metabolism will now be discussed. 
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1.2.1 Glucose metabolism – a brief synopsis 
Cardiac glucose uptake is controlled by membrane-bound molecules known as glucose 
transporters (GLUTs). There are two major GLUT isoforms in the heart, i.e. GLUT1 and 
GLUT4 [66]. GLUT1 is the foetal isoform and is also non-insulin responsive while GLUT4 
is the major adult isoform and is insulin responsive. Upon insulin stimulation, GLUT4 
vesicles are translocated to the sarcolemma, thereby resulting in glucose uptake [66, 87].  
Insulin exerts its effects by binding to insulin receptors and more specifically to the external 
α-subunit of the insulin receptor, the internal β-subunit self-phosphorylates, leading to 
tyrosine phosphorylation. This results in increased insulin receptor substrate-1 (IRS-1) and 
downstream PI3-kinase and Akt activity, that ultimately results in translocation of GLUT4 
vesicles to the sarcolemma to facilitate glucose uptake [23]. 
Insulin plays a critical role in nutrient regulation of the circulatory system, especially for 
glucose and amino acids. The major target tissues of insulin are muscles, liver, adipose tissue 
and the satiety centre within the hypothalamus. The satiety centre is a collection of neurons 
sending signals to the brain to control appetite [85]. Insulin, however, does not directly affect 
the nervous system since it binds to membrane-bound receptors on target cells as discussed. 
Insulin and insulin-receptor molecules are endocytosed by the target cell, whereby the insulin 
is subsequently released from the insulin receptors, and broken down within the cell. The 
receptors are released and become membrane-bound again. If glucose is not metabolized 
immediately by the cell it is stored as glycogen in skeletal muscle, liver and other tissues, or 
converted to fat in adipose tissue.  
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Without insulin the ability of cells to take up glucose is minimal, resulting in insulin 
resistance. The regulation of blood glucose levels is partially dependent on insulin. Therefore, 
if inadequate insulin is available glucose levels can increase drastically, leading to 
hyperglycaemia which is also one of the pre-disposing factors that contribute to the onset of 
diabetes and CVD. 
During glycolysis, glucose is converted to glucose-6-phosphate via hexokinase and to 
fructose-6-phosphate by glucose-6-phosphate isomerase. Fructose-6-phosphate is 
subsequently converted to fructose 1,6-bisphosphate by phosphofructokinase, a rate-limiting 
enzyme of glycolysis. The majority of fructose-6-phosphate continues to be metabolized in 
the glycolytic pathway, until its end product, pyruvate, is formed. Interestingly, a relatively 
smaller percentage (~1-3%) enters a nutrient sensing pathway- called the hexosamine 
biosynthetic pathway (HBP) (refer to Figure 1.1) [55, 78, 93]. 
Pyruvate is usually formed under aerobic conditions, while under anaerobic conditions, 
lactate is formed from pyruvate. During the second phase of glucose metabolism, pyruvate 
enters the mitochondrion and undergoes oxidative decarboxylation. This process is catalysed 
by PDH that is located within the inner mitochondrion. PDH activity is usually increased by 
catecholamines or by high glucose levels (during the fed state).  
Conversely, it is inhibited by acetyl-CoA and NADH2 and by products of elevated fatty acid 
oxidation rates. Acetyl-CoA and NADH2 can enter the Krebs cycle while reducing 
equivalents (NADH and FADH2) can enter the electron transport chain to generate ATP [14, 
66]. 
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Fig 1.1: The relationship between glucose uptake and signalling pathways.  
Glucose is one of the major fuel substrates in the heart during the fed state. Glucose, however, follows a 
series of reactions whereby the majority enters the glycolytic pathway and a smaller percentage feeds into 
the hexosamine biosynthetic pathway, which is a nutrient sensing pathway in the heart. The final product of 
the HBP, i.e. UDP-GlcNAc, can be O-linked to target proteins by O-GlcNAc transferase. Conversely, O-
GlcNAcase can remove O-GlcNAc from target proteins. 
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Hyperglycaemia mediates tissue injury by generating reactive oxygen species (ROS) a 
mechanism well established by Brownlee et al. (2005). They propose that hyperglycaemia 
leads to increased glucose oxidation and flux through the electron transport chain rises. As a 
result there is greater mitochondrial superoxide production. Increased superoxide levels lead 
to DNA damage resulting in the activation of poly (ADP-ribose) polymerase (PARP). PARP 
can inhibit glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a key enzyme of the 
glycolytic pathway [19]. The idea is then that such inhibition leads to the accumulation of 
upstream glycolytic metabolites, e.g. fructose-6-phosphate that can subsequently enter 
alternate metabolic pathways [2, 9, 11, 34-35, 37, 38, 55, 57, 75, 78, 80]. These include the 
production of advanced glycation end products (AGEs), increased flux through the HBP, 
polyol pathway and protein kinase C (PKC) activation [19]. 
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1.2.1.1 Hexosamine biosynthetic pathway (HBP) 
Since the focus of this thesis is on the HBP, I will now review the normal function of this 
pathway and also how dysregulated HP flux is linked to the onset of disease states, e.g. 
insulin resistance. Approximately 1-3% of available glucose enters into the HBP [77], where 
it is converted to glucose-6-phosphate with the aid of hexokinase, and then to fructose-6-
phosphate via glucose-6-phosphate isomerase [55, 93]. Here, fructose-6-phosphate enters the 
HBP where it is then converted to glucosamine-6-phosphate via the addition of glucosamine 
(Figure 1.1).  
HBP flux is regulated by glutamine: fructose-6-phosphate amidotransferase (GFAT), its rate-
limiting enzyme. Intriguingly, GFAT overexpression causes insulin resistance, in parallel to 
increased HBP flux. Glucosamine-6-phosphate is converted to N-acetylglucosamine-6-
phosphate by glucosamine-6-phosphate acetyltransferase, which is then converted to N-
acetylglucosamine-1-phosphate by phosphate-acetylglucosamine mutase. The HBP end 
product is formed by the conversion of N-acetylglucosamine-1-phosphate to UDP-GlcNAc 
by the enzyme UDP-N-acetylglucosamine-pyrophosphorylase. 
The final step of the pathway is the formation of uridine-diphosphate (UDP)-N-
acetylglucosamine (GlcNAc) [55]. Many cytoplasmic and nuclear proteins are glycosylated 
on serine and/or threonine residues by the addition of a single O-linked-β-N-
acetlyglucosamine (O-GlcNAc) molecule. Enzymes that are responsible for O-GlcNAc 
modifications are O-GlcNAc transferase (addition of O-GlcNAc) and O-GlcNAcase (removal 
of O-GlcNAc), which is preferentially cleaved by caspase 3. The role of the cleavage process 
is not known, although O-GlcNAcase is deregulated during programmed cell death 
(apoptosis) [98]. 
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The O-glycosylation of proteins is implicated in protein modulation via different mechanisms 
that include i) regulation of protein phosphorylation and protein function; ii) regulation of 
protein degradation; iii) protein localization; iv) protein-protein interaction modulation and 
v) mediating transcription [78]. Data from in vitro studies done on RNA polymerase II 
showed a reciprocal relationship between O-GlcNAc and phosphorylation, where they 
compete for the same serine / threonine residues, thus regulating the levels of each other [12]. 
Although glucose is the main carbon source for HBP activation, fatty acids may also activate 
the HBP. Additionally, the HBP has been linked to both beneficial and detrimental effects. 
For the purpose of this study we focused on the effects that a beneficial monounsaturated 
fatty acid has on the HBP. Increased free fatty acids supply and β-oxidation increase the 
concentration of mitochondrial acetyl-CoA which decreases the rate of pyruvate oxidation via 
PDH inhibition [33]. The entry of fructose-6-phosphate into the glycolytic pathway is limited 
by the inhibition of phosphofructokinase (PFK) , thereby causing an elevated amount of 
fructose-6-phosphate to enter the HBP to form glucosamine (GlcN)-6-P and thus increased 
glycosylation of proteins via an increased formation of the HBP end product, UDP-GlcNAc 
[55, 93].  
Increased flux of fructose-6-phosphate into the glucosamine pathway could lead to an 
impairment of glucose uptake due to the overload of substrate flowing into the HBP, which 
could ultimately lead to glucose-induced insulin resistance. Several studies have showed that 
an increased fructose-6-phosphate flux into the HBP causes decreased glucose uptake in both 
in vivo and in vitro studies which could lead to glucose- and fat-induced insulin resistance 
(Figure 1.2) [2, 9, 11, 34-35, 37, 38, 55, 57, 76, 79, 81]. 
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Fig 1.2 Fatty acids and the HBP.  
An increase in the concentration of available free fatty acids leads to increased mitochondrial fatty 
acid oxidation. Due to the Randle effect PFK and PDH are inhibited resulting in an accumulation of 
upstream metabolites, i.e. fructose-6-phosphate. Thus, there will be increased HBP flux. 
Abbreviations: glutamine: fructose-6-phosphate (GFAT); O-GlcNAc transferase (OGT); pyruvate 
dehydrogenase (PDH); phosphofructokinase (PFK). 
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Essop et al., (2010) recently found, in response to increased glucose levels (hyperglycaemia), 
certain apoptotic proteins are O-GlcNAcylated [73, 74]. This was associated with higher 
oxidative stress and apoptosis in a heart cell line. Overall, our laboratory found that increased 
BAD O-GlcNAcylation results in less BAD becoming phosphorylated thereby causing more 
Bcl-2 proteins to dimerize with BAD, thus increasing Bax protein availability. 
Homodimerization of Bax causes the disruption of the mitochondrial membrane which leads 
to an increased number of cells becoming apoptotic [73, 74]. We also found that this pathway 
was induced in a rat model of diet-induced insulin resistance [73, 74]. 
However, others have found that an increase in O-Glycosylation can have cardioprotective 
effects. Chatham et al. (2010) found that glucosamine improved the cardiac functional 
recovery following an ischemic insult that was linked to increased O-Glycosylation [8]. It 
was further established that ERK1/2 and Akt responses were not altered by glucosamine; but 
merely attenuated the ischemic-induced increase in p38 phosphorylation. Thus, proposed that 
O-GlcNAcylation plays an important role as an internal stress response regulator, and such 
cardioprotection may involve the p38 MAPK pathway [26]. 
These studies therefore show conflicting outcomes when HBP is activated and further studies 
are required to resolve this. However, we are of the opinion that these outcomes depend on 
the particular intracellular context, i.e. acute vs. chronic and postulated that within the acute 
setting, specific proteins are targeted for O-GlcNAcylation, leading to cardioprotection. 
However, with chronic HBP activation, different proteins are targeted for O-GlcNAcylation, 
thus leading to detrimental outcomes, such as increased oxidative stress and apoptosis. These 
possibilities are currently being investigated in our group. 
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1.2.2 Fatty acid metabolism 
Fatty acids are an important energy source for mammals and compromises ~80% of oxidative 
metabolism in humans [5, 15, 24, 49-51, 72]. Fatty acids have four important functions in the 
human body: i) they are the building blocks of phospholipids and glycolipids which 
constitute the cell membrane; ii) they are attached to proteins, which assist in directing them 
to their correct place within membranes; iii) are stored as triacylglycerols and iv) fatty acids 
and its products function as messenger molecules [90] and act on pancreatic β-cells, thus 
regulating glucose-stimulated insulin secretion [31, 86]. 
Long-chain fatty acids (LCFAs) provide 70-80% of the energy to sustain the heart‟s function 
[87, 97]. LCFAs are transported into the myocardium via protein-mediated LCFA 
transporters where uptake and oxidation is controlled by specific LCFA binding proteins 
which play an important role in LCFA movement across cellular membranes. The controlled 
movement of LCFAs into the cardiac myocytes contributes to the regulation of LCFA 
metabolism in healthy hearts.  
Excess LCFAs (e.g. obesity, diabetes), contributes to the accumulation of toxic lipid 
metabolites (lipotoxicity) as well as glucose accumulation due to a lack of insulin 
responsiveness (glucotoxicity), which are associated with excess substrate accumulation in 
the heart [10, 71, 80, 91]. Several LCFA transporters are expressed in the heart, including an 
88-kDa fatty acid translocase (FAT)/CD36, plasma membrane associated fatty acid binding 
proteins (FABP) and fatty acid transport proteins (FATP) [5, 51, 72]. 
Circulating free fatty acids (FFAs) are released into the bloodstream where they are then 
transported across the sarcolemma and into cardiomyocytes via mitochondrial membrane 
transporters. They are subsequently transferred to heart-type fatty acid-binding proteins (H-
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FABP). It has recently been shown that one of the LCFA transporters, FATP1, displays acyl-
CoA synthetase activity.  
Following uptake, long-chain acyl-CoAs are complexed with acyl-CoA binding proteins 
(ACBP) (Figure 1.3) that can be transported to mitochondria for β-oxidation (70-80%). 
Alternatively, fatty acyl-CoAs can be esterified (10-30%) for triacylglycerol (TG) formation. 
Lipotoxicity is the result of a mismatch between lipid oxidation and lipid uptake [10, 71]. 
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Fig 1.3 Schematic representation of protein-mediated, long-chain fatty acid uptake and its 
metabolism in cardiomyoblasts.  
FAT/CD36 - fatty acid translocase; FABP - fatty acid-binding protein; FATP - fatty acid transport 
protein; ACBP - acyl-CoA binding protein; FA – fatty acids 
 
Fatty acids are activated by the addition of coenzyme-A (catalysed by long-chain acyl 
Coenzyme-A synthase) after which mitochondrial uptake follows. The regulation of fatty acid 
metabolism is achieved by a series of reactions, involving the transport of fatty acids into the 
inner matrix of the mitochondrion where fatty acids are oxidized. Mitochondrial fatty acid 
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uptake is regulated by the rate-limiting enzyme CPT-1. CPT-1 is controlled by malonyl-CoA, 
a potent inhibitor [46-47, 65, 77, 82-83, 88, 101].  
Upstream, acetyl-CoA carboxylase (ACC) synthesizes malonyl-CoA (from acetyl-CoA), 
while malonyl-CoA decarboxylase (MCD) can degrade malonyl-CoA [34-36, 39, 42, 43]. 
Thus, ACC and MCD activity can tightly regulate intracellular malonyl-CoA levels and 
mitochondrial fatty acid uptake [22]. 
Following mitochondrial uptake, fatty acids are catabolized via β-oxidation to ultimately 
generate reducing equivalents (NADH, FADH2) that can enter the electron transport chain for 
ATP production [66].  
A short review of the different types of fats and potential beneficial effects will follow with 
the main focus on oleic acid. 
 
1.2.2.1 Unsaturated versus saturated fatty acids 
A fatty acid is a carboxylic acid with a long unbranched carbon chain. Fatty acids are classed 
into three groups namely, monounsaturated, polyunsaturated and saturated fatty acids. 
Unsaturated fatty acids resemble saturated fatty acids, except its chain possesses one or more 
double bonds between the carbon atoms. Adjacent double-bonded carbons are in the cis-
configuration, while double-bonded carbons situated across each other are in the trans-
configuration. This configuration is important since fatty acid fluidity is affected in a 
restricted environment [1, 17, 95, 97].  
Biological active fats are categorized as „good fats‟ (comprising monounsaturated and 
polyunsaturated fatty acids), and „bad fats‟ (comprising saturated and trans fatty acids) [52, 
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70, 92]. Broadly speaking, unsaturated fatty acids are enriched in fruits, vegetables, nuts and 
seeds, whereas saturated and trans fatty acids are typically found in meat, dairy products, 
refined oils and processed foods [52, 70, 92]. 
Saturated fatty acids are generally solid at room temperature. High intake of saturated fatty 
acids causes elevated cholesterol levels that lead to increased production of low-density 
lipoproteins (LDL). When LDL is present in excess, it can result in blocked arteries that may 
lead to atherosclerosis [56]. 
Trans fatty acids are detrimental to overall well-being. Like saturated fats, trans fats can also 
cause an increase in LDL levels, thus increasing the risk of CVD [56]. Moreover, in line with 
global trends, trans fats are often used in processed and packaged foods, as it increases the 
shelf-life of these foods. 
Conversely, mono- and polyunsaturated fatty acids can reduce LDL and cholesterol levels 
[56]. The Mediterranean diet is a well know source of high monounsaturated fatty acid 
content and is linked with lower incidences of coronary heart disease (CHD) [56]., It has also 
been shown that the long-chain dietary polyunsaturated fatty acids, eicosapentaenoic acid 
(EPA) and arachidonic acid (ARA) protected neonatal rat cardiomyocytes from the damaging 
effects of simulated ischemia and reperfusion [21]. 
The latter two fatty acids decreased apoptosis through activation of extracellular signal-
regulated kinase (ERK) and by de-phosphorylation of the pro-apoptotic kinase, p38 [21]. 
Mackay and Mochly-Rosen also found that ARA exerts its protective effects by selectively 
activating protein kinase C delta and epsilon (PKCδ, PKCε) [53] In agreement, long-term 
EPA and docosahexaenoic (DHA) treatment protected rat heart cells from hypoxia-
reoxygenation injury [36]. Unsaturated fatty acids are recommended by dieticians as they 
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reduce the amount of calories compared to saturated and trans fatty acids. The following 
section will focus on studies that investigated the protective effects of oleic acid. 
 
1.2.2.2 Oleic acid 
One of the major monounsaturated fatty acids is oleic acid (18:1 9), an omega-9 fatty acid 
having 18 carbon atoms and a cis double bond at carbon 9 (Small, 2000). Sources of these 
fatty acids can be found in animal and vegetable oils such as olive oil and also grape seed and 
sea buckthorn oils. Stearoyl-CoA desaturase (SCD) catalyzes the biosynthesis of 
monounsaturated fatty acids from saturated fatty acids with preferred substrates including 
palmitoyl- and stearoyl-CoA, which are then converted into palmitoleoyl- and oleoyl-CoA, 
respectively [68]. Thus oleate can also be produced by palmitate metabolism. However, 
excess palmitate is known to have damaging effects, e.g. resulting in increased myocardial 
apoptosis [61]. Interestingly, low levels of oleate treatment was able to blunt detrimental 
effects of palmitate in heart cells [61]. Although palmitate has damaging effects in the heart, 
this may be undone by increased metabolism of oleate which has cardio-beneficial effects. 
Oleic acid has the ability to assist in certain beneficial functions such as reducing the 
development of atherosclerosis; decreasing serum cholesterol; diminishing oxidative stress 
and inflammatory mediators, and delaying the onset of adrenoleukodystrophy [62].  
Omega-9 fatty acids reduce risk factors that contribute to CVD and diabetes, i.e. increase 
HDL cholesterol and to reduce LDL cholesterol, thus eliminating plaque formation in the 
arteries [56]. Due to high unsaturated fatty acid content, omega-9 fatty acids also reduce the 
risk of CAD [56]. 
Stellenbosch University http://scholar.sun.ac.za
20 
 
Omega-3 fatty acids are known to have anti-inflammatory properties, while omega-6 fatty 
acids may have pro-inflammatory properties [27]. However, the effect of omega-9 on 
inflammation is not clear yet, although a number of studies have found that a high 
monounsaturated Mediterranean diet and / or consumption of olive oil can reduce 
inflammation [16, 40, 42, 45, 56, 67, 94]. 
Oleic acid also has the ability to activate PKC which in turn activates ERK [28, 44, 48, 63, 
84]. ERK activation is a marker for cell growth and differentiation in response to several 
mitogens [18, 41]. A recent study also found that oleic acid has the ability to reverse the 
inhibitory effects of insulin production of the inflammatory cytokine (TNF-α). Oleic acid 
influenced expression of 14 genes, e.g. transcription factors such as the early response growth 
factor (EGR-1), ubiquitin and proteins involved in proteolysis. Interestingly, oleic acid is able 
to inhibit palmitate-induced oxidative stress, stress-associated protein kinases (p38, ERK1/2, 
JNK) and apoptosis in cardiac myocytes [61]. 
Although omega 3 and 9 fats are linked to cardioprotection (at population level) there are, as 
far as we are aware, no detailed heart studies done to determine cellular mechanisms whereby 
oleic acid could trigger cardioprotection. This served as a point of origin to investigate 
whether oleic acid possesses any anti-oxidant and / or anti-apoptotic properties that may 
explain its link to cardioprotection. 
Together this literature review shows that various metabolic fuels (e.g. fatty acids and 
glucose) are required for optimal output by the mammalian heart. The regulation of fuel 
substrate supply is tightly controlled at multiple levels e.g. hormonal, cellular uptake, 
metabolic flux, gene, protein regulation, enzyme activity level, post-translational 
modification etc.  Thus the organism needs to integrate a variety of signals at any instance to 
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ensure optimal fuel substrate selection and its breakdown to supply mitochondrial ATP to 
sustain the heart.  The host organism is therefore finely tuned to achieve this balance or 
„‟homeostasis‟‟.   
However, on some occasions homeostatic balance cannot be restored, e.g. due to chronic 
factors (external or internal) that impact on the heart and the organism. In such instances, 
there may be a deficient or oversupply of metabolic fuels in the bloodstream and this in turn 
will determine the heart‟s choices for substrate selection.  Under these circumstances the 
heart may utilize an excess of an available fuel substrate, e.g. chronic fatty acid utilization by 
the diabetic heart. This in turn may eventually impair contractile function.   
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1.3 Hypothesis 
As discussed earlier, excess fat and/or carbohydrate intake results in homeostatic imbalance. 
For example, in our laboratory we propose that elevated blood glucose levels 
(hyperglycemia) are damaging to the heart and results in cardiac contractile dysfunction. 
Here we propose that increased HBP flux results in greater O-GlcNAc modified signalling 
proteins that may eventually trigger oxidative stress and myocardial death. However, elevated 
HBP flux may also lead to cardio-protection – dependent on the particular context – and for 
the current study we therefore hypothesized that increased oleic acid availability will enhance 
HBP flux either directly or indirectly through alternative (but associated) pathways. This in 
turn will post-translationally modify different target proteins (increased protein O-
GlcNAcylation), and thereby diminish oxidative stress and myocardial apoptosis, thus acting 
as a novel cardio-protective agent. 
 
1.4 Aims 
The aims of this study were three fold: 
1. To evaluate whether oleic acid treatment increases HBP flux in H9c2 myoblasts 
2. To determine whether oleic acid-induced HBP activation results in decreased oxidative 
stress; and lastly 
3. To assess whether oleic acid-induced HBP activation results in attenuated myocardial 
apoptosis. 
Stellenbosch University http://scholar.sun.ac.za
23 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University http://scholar.sun.ac.za
24 
 
2.1 Origin of H9c2 cardiomyoblasts 
We employed rat-derived cardiovascular H9c2 cells for our in vitro studies. Kimes et al. 
(1976) [2] initiated the H9c2 cell line derived from an embryonic rat heart, and which is a 
useful cell line to simulate heart studies. Hescheler and co-workers (1991) [1] found that 
H9c2 cells have dihydropyridine-sensitive calcium channels that respond to beta-adrenergic 
stimulation. During rapid proliferation, calcium channels are sparse or absent, though at least 
two distinct potassium channels and a non-specific cation channel are observed [4]. The latter 
conduct calcium, sodium and potassium with similar efficacy.  
 
2.2 Cell culture: H9c2 cardiomyoblasts 
The H9c2 cardiomyoblast cell model was employed for the present study. Rat-derived H9c2 
cardiomyoblasts were cultured in a T75 culture flask at a density of 10
6
 cells/15 ml of low 
glucose Dulbecco‟s Modified Eagles Medium (DMEM) (Sigma-Aldrich, Steinheim, 
Germany). The DMEM was supplemented with 10% foetal bovine serum (Invitrogen, 
Carlsbad, CA) and 1% penicillin-streptomycin (Sigma, Steinheim, Germany) to reduce 
contamination. Cells were incubated overnight at a temperature of 37
o
C, 95% air and 5% 
CO2. The following day the medium was changed to discard all non-adherent cells. 
Subsequently, the adherent cells were further cultured in fresh medium and left to grow to 
between 70-80% confluence, where after cells were sub-cultured for further experiments. We 
ensured that the medium was regularly checked and replaced, since increased confluency 
depletes nutrients that may cause cells to detach from the flask surface and die.  
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2.3 Experimental protocol 
After reaching 70-80% confluence, cells were sub-cultured. The cells were washed with 3 ml 
phosphate buffered saline (PBS) and thereafter treated with 4 ml trypsin (Sigma, Steinheim, 
Germany). This was followed by ~ 2 minutes incubation at room temperature to allow for 
cells to detach from the surface of the culture flask. Subsequently, 8 ml of fresh DMEM 
(Sigma, Steinheim, Germany) was added to the flask, bringing the total volume to 12 ml. 
After the contents were aspirated, 10 µl was transferred onto a hemocyter (Marienfeld, 
Germany) for counting. The remainder of the cell suspension was centrifuged (Orto Alresa, 
Digicen 20-R) for 3 minutes at 1,500 x g at 37°C. The supernatant was discarded and the 
pellet re-suspended in fresh DMEM according to the volume calculated from the 10 µl of 
cells that was used for counting (refer Appendix 1). Using this suspension, 250,000 cells / 5 
ml DMEM (Sigma, Steinheim, Germany) were cultured in a T25 culture flask. The cells were 
incubated overnight at 37°C, 5% CO2 and 95% air. The following day the medium was 
discarded, fresh medium added and cells were again incubated overnight.  
We initiated our treatment protocol on the third day. Our strategy included the use of 0.25 
mM oleic acid (OA) (Sigma, Steinheim, Germany) [5] and 40 µM DON (Sigma, St. Louis, 
MO) [3] that were added at different times to ensure that we adhered to our protocol (refer to 
Fig 2.1). Three time points, i.e. 24, 48 and 72 hour exposure time to OA (Sigma, Steinheim, 
Germany) were followed. The OA used to treat the cells was metabolised by the cells bound 
to albumin, in an undiluted form. To assess the effect of the hexosamine biosynthetic 
pathway (HBP) on our experimental system, we employed DON (GFAT inhibitor) (Sigma, 
St. Louis, MO) that was added 12 hours before the conclusion of the experiment (refer to Fig 
2.1). DON was initially administered closer to the time that the cells were analysed (5-6 hrs). 
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However, since only minor changes were observed, we doubled exposure time to DON to 
allow for increased time for it to exert its known intracellular effects. 
Upon completion of these experiments, we assessed various parameters to evaluate the 
validity of our hypothesis. Specifically, we determined the degree of oxidative stress; O-
GlcNAcylation (HBP flux) and apoptosis by using flow cytometry as well as 
immunofluorescence microscopy (refer to Tables 2.1-2.2). 
 
Cells cultured to 70-80% confluence 
Control Oleic acid (OA) DON DON + OA 
 
 
 
 
 
 
 
 
 
Fig 2.1 Overall experimental lay-out of this study 
 
Untreated 
(72 hours) 
 
Treated for 24 hrs, 
48 hrs, 72 hrs, 
respectively 
 
Treated 12 hrs 
prior to analysis 
(for 24 hrs, 48 hrs 
and 72 hrs time 
points, 
respectively) 
Treated with OA for 
24, 48 and 72 hrs. 
DON 
was administered 12 
hours prior to 
analysis (to each of 
24, 48 and 72 hrs time 
points, respectively) 
Treatment groups: 
Apoptosis; Reactive-oxygen species (ROS) production and O-
GlcNAcylation  
[Flow cytometry; Immunofluorescence microscopy and Caspase Glo 
Assay apoptosis only)] 
Figure 2.1 Overall experimental lay-out of this study. 
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2.3.1 Technique protocols 
 
 
Day 
 
FLOW CYTOMETRY 
Experimental preparation: culture flasks 
 
1 
 
250,000 (250 µl) cells from cell suspension (refer Section 2.3) were re-suspended in 5 ml 
DMEM in a T25 culture flask. The cells were incubated overnight at 37°C, 95% air and 
5% CO2 (10 flasks are prepared per experiment). 
 
2 
 
Medium was discarded from all the flasks to remove non-adherent cells and fresh medium 
added. Cells were incubated overnight before treatment regimens were employed. The 
control flask remained untreated throughout the experiment. 
  
0.25 mM Oleic Acid (OA) 
 
40 µM   DON 
 
40 µM   DON + 0.25 mM 
OA 
 
3 
 
378 µl OA into “72 hr flask” 
 
No treatment 
 
378 µl OA into “72 hr 
flask” 
 
4 
 
378 µl OA into “48 hr flask” 
 
No treatment 
 
378 µl OA into “48 hr 
flask” 
 
 
5 
 
378 µl OA into “24 hr flask” 
 
No treatment 
 
378 µl OA into “24 hr 
flask” 
 
No treatment 
 
12 hrs prior to staining DON was administered where 
required (refer to Appendix 2 for calculations) 
 
Table 2.1 Experimental design for the flow cytometry experiments. 
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Day 
 
IMMUNOFLUORESCENCE MICROSCOPY 
Experimental preparation: 8-well LabTek chambers 
 
1 
 
20,000 (20 µl) cells from the cell suspension (refer Section 2.3) were re-suspended in 500 
µl DMEM per well. The cells were incubated overnight at 37°C, 95% air & 5% CO2 (3 
chambers were prepared per experiment). 
 
2 
 
The medium was discarded from all wells to remove the non-adherent cells and replaced 
with fresh medium. Cells were incubated overnight before treatment. The control and PBS 
control wells remained untreated. 
  
0.25 mM Oleic Acid (OA) 
 
40 µM  DON 
 
40 µM DON + 0.25 mM 
OA 
 
3 
 
37.8 µl OA into “72 hr well” 
 
No treatment 
 
37.8 µl OA into “72 hr 
well” 
 
4 
 
 37.8 µl OA into “48 hr well” 
 
No treatment 
 
37.8 µl OA into “48 hr 
well” 
 
 
5 
 
37.8 µl OA into “24 hr well” 
 
No treatment 
 
37.8 µl OA into “24 hr 
well” 
 
No treatment 
 
12 hrs prior to staining DON was administered where 
required (refer to Appendix 2 for calculations) 
 
Table 2.2 Experimental design for the immunofluorescence experiments. 
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2.4 Measurement of oxidative stress 
2.4.1 Flow cytometry: H2DCF-DA staining 
Cells were cultured as before to analyse cellular oxidative stress (refer Section 2.2 and 2.3). 
After the five-day experimental protocol (refer Table 2.1) was completed, the medium from 
all flasks was removed, cells were washed with 3 ml of warm PBS and thereafter treated with 
4 ml trypsin (Sigma, Steinheim, Germany) for 2 minutes. After cell detachment, 8 ml DMEM 
(Sigma, Steinheim, Germany) was added to each flask. Following this, each flask‟s contents 
was transferred to a 50 ml plastic tube (Falcon) where after it was centrifuged (Orto Alresa, 
Digicen 20-R) at 1,200 x g for 20 seconds. The supernatant was discarded and pellets re-
suspended in 200 µl H2DCF-DA dye which was calculated according to the supplier protocol 
(R&D Systems, Minneapolis, MD). A 1:200 dilution of ROS dye was prepared from a 1M 
stock solution by diluting it with sterile 1 x PBS. Flasks were incubated at 37°C for 10 
minutes wrapped in foil. 
Subsequently, the dye was aspirated and samples centrifuged (Orto Alresa, Digicen 20-R) at 
1,200 x g for 20 seconds. The supernatants were discarded and the pellets were re-suspended 
in 300 µl warm PBS. The tubes were thereafter wrapped in foil and analysed using a BD 
FACSAria™ flow cytometer (Becton-Dickinson, CA) to evaluate oxidative stress.  
The cell suspension was transferred from the 50 ml plastic tubes to specialized glass tubes for 
cytometric analysis. A total number of 5,000 – 10,000 events (cells) were collected per 
condition per experiment (each at different time points). This was a total of ~ 60,000 cells per 
experiment that was analysed, of which three independent experiments were conducted  using 
the 488 nm laser; 520 LP and the 530/30 P emission filters were employed for the green 
signal (FITC colour channel was used).  
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The fluorescent intensity signal was measured by using the geometric mean on the intensity 
histogram for each condition. The geometric mean of each condition was then calculated in 
relation to the control (normalized) to evaluate the level of fluorescent intensity as a 
percentage across the time points, which was set equal to 100%. These intensity signals were 
used for statistical analysis. Intensity signals that were more than double the standard 
deviation were omitted. Each experiment was analysed independently (n=3). 
The fluorescent peak of the H2DCF-DA dye (R&D Systems, Minneapolis, MD) on the 
histogram was used an indication of the overall degree of oxidative stress within the cell. A 
shift to the right indicated more oxidative stress in the selected events (number of cells 
analysed) whereas a shift to the left indicates less oxidative stress.  The forward scatter (FSC) 
and the side scatter (SSC) on the system are indicators of the size of cells; the cells internal 
complexity as well as the fluorescence intensity (refer to Fig 2.2). 
 
 
Fig 2.2 Flow cytometry fluorescent intensity histogram. 
Here, P1 indicates all the events analysed; P2 indicates only the FITC-A positive events 
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2.4.2 Immunofluorescence microscopy: H2DCF-DA staining 
Cells were cultured as before (refer Section 2.2 and 2.3) for the analysis of oxidative stress. 
After the 5-day experimental protocol (refer Table 2.2) was completed, the medium from all 
wells was removed, whereafter each well was washed with 300 µl warm PBS. PBS was 
subsequently removed and cells in each well re-suspended in 200 µl H2DCF-DA dye (R&D 
Systems, Minneapolis, MD). A 1:200 dilution of H2DCF-DA dye (R&D Systems, 
Minneapolis, MD) was prepared from a 1M stock solution by diluting it with sterile 1 x PBS. 
The chambers were incubated at 37°C for 10 minutes wrapped in foil. 
Subsequently, the dye was aspirated and removed from each well. Wells were rinsed with 
300 µl warm PBS and thereafter re-suspended in 200 µl Hoechst dye (Sigma, Steinheim, 
Germany) for 10 minutes. The dye was then removed and wells twice washed with 300 µl 
warm PBS. The chambers were wrapped in foil for the assessment of the degree of oxidative 
stress on the Olympus Cell^
R
 system attached to an 1X-81 inverted fluorescence microscope 
(Olympus Biosystems, Germany) equipped with a F-view-II cooled CCD camera (Soft 
Imaging Systems, Germany).  
Using a Xenon-Arc burner (Olympus Biosystems GMBH) as a light source, images were 
excited with the 360 nm, 472 nm or 572 nm excitation filter. Emission was collected using a 
UBG triple-bandpass emission filter cube. Each well was imaged individually using the 100x 
magnification on the oil immersion lens and Cell^
R 
imaging software. Each experiment was 
imaged independently, where four images per well were taken per condition, thus having a 
total number of 16 images per time point and 40 images per experiment. In each image there 
were 10-20 cells that were imaged, thus a total number of 400-800 cells were imaged per 
experiment. Moreover, this experiment was repeated three times (independently). 
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Each image was background subtracted and the regions of interest (ROI) for each cell in a 
single image were selected for which the fluorescent intensity was automatically calculated 
by the Cell^
R 
software and averaged. The average of each ROI per condition of cells imaged 
per time point was used for statistical analysis. Each experiment was analysed independently 
(n=3). 
The fluorescent intensity of the H2DCF-DA dye (R&D Systems, Minneapolis, MD) was an 
indication of the degree of oxidative stress. The FITC colour filter was used, observed as a 
green fluorescent staining of the cell cytoplasm, to measure overall oxidative stress within the 
cell. The degree of green intensity reflected the degree of oxidative stress. 
 
2.5 Evaluating the level of O-GlcNAcylation: an indication of HBP flux 
2.5.1 Flow cytometry 
Cells were cultured to measure the degree of O-GlcNAcylation (refer Section 2.2 and 2.3). 
After the 5-day experimental protocol (refer Table 2.1) was completed, medium was removed 
and each flask washed with 3 ml warm PBS. Thereafter, the cells in each flask were treated 
with 4 ml trypsin (Sigma, Steinheim, Germany) for 2 minutes to allow cells to detach from 
culture flask surfaces. After detachment, 8 ml DMEM (Sigma, Steinheim, Germany) was 
added to each flask, the cell suspension in each flask was then transferred to 50 ml plastic 
tubes and centrifuged (Orto Alresa, Digicen 20-R) for 20 seconds at 1,200 x g. Thereafter, the 
supernatant in each tube was discarded, and the pellets re-suspended in 300 µl cold PBS 
followed by centrifugation (20 seconds, 1,200 x g). The supernatant was discarded; pellets re-
suspended in 300 µl of a 1:1 methanol/acetone fixative and incubated for 10 minutes at 4°C. 
Subsequently, samples were re-centrifuged (Orto Alresa, Digicen 20-R) (1,200 x g, 20 
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seconds) and the supernatant discarded. In the meantime, a 5% donkey serum in PBS (5 mL) 
stock solution was prepared and 200 µl added per flask to block non-specific binding sites. 
Samples were incubated for 10 minutes at room temperature, where after the supernatant was 
discarded (no centrifugation and no washing). A 1:200 dilution of primary anti-goat antibody 
(Pierecenet, Woburn, MA) in PBS stock solution was prepared. We added 100 µl from the 
stock solution to each tube, followed by incubation for 30 minutes in the dark at room 
temperature. Subsequently, the samples were centrifuged and the supernatants discarded. The 
pellets were washed with 300 µl cold PBS, re-centrifuged (Orto Alresa, Digicen 20-R) at 
1,200 x g for 20 seconds and the supernatants discarded. 
A 1:200 dilution of secondary anti-mouse PE-Texas Red antibody (Invitrogen, Carlsbad, CA) 
in PBS stock solution was then prepared, where after 100 µl was added to each tube and 
incubated for 30 minutes at room temperature in the dark. Following this, 100 µl of Hoechst 
dye (Sigma, Steinheim, Germany) (1:200 dilution in PBS) was added and incubated for 10 
minutes at room temperature in the dark. All reagents and dyes should be kept on ice and in 
the dark throughout the staining procedure due to light sensitivity. 
Samples were thereafter centrifuged (Orto Alresa, Digicen 20-R) at 1,200 x g for 20 seconds 
and the supernatants discarded. We then washed samples with 300 µl PBS, re-centrifuged 
(1,200 x g for 20 seconds) and added 300 µl PBS to the final pellet. Subsequently, samples 
were wrapped in foil while transporting it to a BD FACSAria™ Flow Cytometer (Becton-
Dickinson, CA) for analysis.  
Prior to analysis, the cell suspension was transferred from the 50 ml plastic tubes to 
specialized glass tubes for cytometric analysis. A total number of 5,000 – 10,000 events 
(cells) were collected per condition per experiment (each at different time points). This was a 
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total of ~ 60,000 cells per experiment that was analysed, of which three independent 
experiments were conducted using the 488 nm laser; 610 LP and the 616/23 BP emission 
filters were employed for the red signal (PE-Texas Red colour channel was used). The 
fluorescent intensity signal was measured by using the geometric mean on the intensity 
histogram for each condition.  
The geometric mean of each condition was then calculated in relation to the control 
(normalized), to evaluate the level of fluorescent intensity as a percentage across the time 
points, which was set equal to 100%. These intensity signals were used for statistical 
analysis. Intensity signals that were more than 2x the standard deviation were omitted. Each 
experiment was analysed independently (n=3). 
 
2.5.2 Immunofluorescence microscopy 
Cells were cultured as before to assess the degree of O-GlcNAcylation by imaging (refer 
Section 2.2 and 2.3). After the five day experimental protocol (refer Table 2.2) was 
completed, the medium from all wells was removed using a vacuum pump. Each well was 
thereafter washed with 300 µl of warm PBS and cells fixed for 10 minutes at 4°C by using 
300 µl of a 1:1 methanol/acetone fixative. Subsequently, the fixative was removed and wells 
left to air dry for 20 minutes. In the meantime, a 5% donkey serum in PBS (5 mL) stock 
solution was prepared, which was used in later steps of the staining process.  
Thereafter, wells were washed with 300 µl cold PBS followed by the addition of 50 µl of 5% 
donkey serum to block non-specific binding sites. Samples were incubated for 20 minutes at 
room temperature, where after the serum was drained (no centrifuging and no washing) and a 
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1:200 dilution of primary antibody in PBS stock solution added (100 µl). Samples were 
thereafter incubated overnight wrapped in foil at 4°C.  
The following day the primary antibody was drained using a vacuum pump and each well 
washed with 300 µl PBS. A 1:200 dilution of secondary anti-mouse Texas Red antibody 
(Invitrogen, Carlsbad, CA) in PBS stock solution was then prepared, of which 100 µl was 
added to each well and incubated for 30 minutes at room temperature in the dark. We 
thereafter added 100 µl of Hoechst dye (Sigma, Steinheim, Germany) (1:200 dilution in PBS) 
to each well and incubated for a further 10 minutes at room temperature in the dark. All 
reagents and dyes should be kept on ice and in the dark throughout the staining procedure due 
to light sensitivity. Wells were twice washed with 300 µl PBS to prevent cell dehydration.  
The chambers were wrapped in foil while conveying it to an Olympus Biosystems 
Immunofluorescent Microscope (Olympus Biosystems, Germany) for cell imaging. The 
Olympus Cell^
R
 system is attached to a 1X-81 inverted fluorescence microscope (Olympus 
Biosystems, Germany) equipped with an F-view-II cooled CCD camera (Soft Imaging 
Systems, Germany). Using a Xenon-Arc burner (Olympus Biosystems GMBH) as a light 
source, images were excited with the 360 nm, 472 nm or 572 nm excitation filter. Emission 
was collected using a UBG triple-bandpass emission filter cube.  
Each well was imaged individually using the 100x magnification on the oil immersion lens 
and Cell^
R 
imaging software. Each experiment was imaged independently, where four images 
per well were taken per condition, thus having a total number of 16 images per time point and 
40 images per experiment. In each image there were 10-20 cells that were imaged, thus a total 
number of 400-800 cells were imaged per experiment. Moreover, this experiment was 
repeated three times (independently).Each image was background subtracted and the ROI for 
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each cell in a single image were selected for which the fluorescent intensity was 
automatically calculated by the Cell^
R 
software and averaged. The average of each ROI per 
condition of cells imaged per time point was used for statistical analysis. Each experiment 
was analysed independently (n=3). 
The level of O-GlcNAcylation can be observed by the fluorescent intensity of the Texas Red 
in the cytoplasm. The fluorescent intensity of the Texas Red dye (Invitrogen, Carlsbad, CA) 
was an indication of the degree of O-GlcNAcylation. The Texas Red filter was used, 
observed as a red fluorescent staining of the cell cytoplasm, which measured the protein O-
GlcNAcylation within the cell. The more intense the red signal observed was, the more 
protein O-GlcNAcylation occurred, an indication of increased HBP flux. 
 
2.6 Assessment of apoptosis & necrosis 
2.6.1 Flow cytometry: Propidium iodide & Annexin V staining 
Cells were cultured for apoptotic cell analysis (refer Section 2.2 and 2.3). After the five day 
experimental protocol (refer Table 2.1) was completed, DMEM (Sigma, Steinheim, 
Germany) in all flasks were discarded and cells washed with 3 ml of warm PBS. Thereafter, 
cells in each flask were treated with 4 ml of trypsin (Sigma, Steinheim, Germany) for two 
minutes to allow for detachment from the culture flask surface. After detachment, 8 ml 
DMEM (Sigma, Steinheim, Germany) was added to each flask.  
The cell suspension in each flask was transferred to individual 50 ml tubes and centrifuged 
(Orto Alresa, Digicen 20-R) for 20 seconds at 1,200 x g at 37°C. Thereafter supernatants 
were discarded and pellets re-suspended in 500 µl cold CaCl2 PBS (refer Appendix 3 for 
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calculation). The CaCl2 PBS assists with the binding of the dye. The tubes were re-
centrifuged (Orto Alresa, Digicen 20-R) at 1,200 x g for 20 seconds at 37°C.  
Thereafter the supernatants were discarded and cell suspensions re-suspended in 100 µl 1x 
binding buffer (R&D Systems, Minneapolis, MD) followed by centrifugation (Orto Alresa, 
Digicen 20-R) for 20 seconds at 1,200 x g at 37°C. After discarding the supernatants, pellets 
in each tube were re-suspended in 100 µl binding buffer and 10 µl Annexin V dye (R&D 
Systems, Minneapolis, MD).  
Samples were incubated for 15 minutes in the dark at room temperature and thereafter 
centrifuged (Orto Alresa, Digicen 20-R) at 1,200 x g for 20 seconds. After the supernatants 
were discarded, pellets were washed with 50 µl 1x binding buffer (R&D Systems, 
Minneapolis, MD) and re-centrifuged (Orto Alresa, Digicen 20-R) (1,200 x g for 20 seconds). 
After the supernatants were discarded, this step was repeated and final pellets were re-
suspended in 5 µl propidium iodide dye (R&D Systems, Minneapolis, MD) and 100 µl 1x 
binding buffer (R&D Systems, Minneapolis, MD).  
The cells were then immediately viewed on a BD FACSAria™ Flow Cytometer (Becton-
Dickinson, CA). The early phase apoptotic cells were viewed in the fourth quadrant (Q4) 
(absorbed the Annexin V dye), the second quadrant (Q2) indicated cells that were necrotic 
(propidium iodide stained) and in the late apoptotic phase (Annexin V stained). Moreover, 
the first quadrant (Q1) represented only the necrotic cell population, and the third quadrant 
(Q3) indicated all the viable cells.(refer to Fig 2.3).  
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Fig 2.3. Flow cytometry quadrant lay-out. 
The cell suspension was transferred from the 50 ml plastic tubes to specialized glass tubes for 
cytometric analysis. A total number of 5,000 – 10,000 events (cells) were collected per 
condition per experiment (each at different time points). This was a total of ~ 60,000 cells per 
experiment that was analysed, of which three independent experiments were conducted using 
the 488 nm laser; 520 LP and the 530/30 P emission filters were employed for the green 
signal (FITC colour channel was used). The fluorescent intensity signal was measured by 
using the cell number in each quadrant out of 100% of P1 (whole population analysed) on the 
intensity histogram for each condition.  
The apoptotic / necrotic cell number of each condition was then calculated in relation to the 
control. These intensity signals were used for statistical analysis. Intensity signals that were 
more than 2x the standard deviation were omitted. Each experiment was analysed 
independently (n=3). 
The fluorescent peak of the Annexin-V dye (R&D Systems, Minneapolis, MD) on the 
histogram was used as an indication of the number of apoptotic cells. A shift to the right 
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indicates more apoptosis in the selected events, whereas a shift to the left indicates less 
apoptosis.  The forward scatter (FSC) and the side scatter (SSC) on the system are indicators 
of cell size and, internal complexity, as well as fluorescence intensity respectively. 
 
2.6.2 Immunofluorescence microscopy: Hoechst staining 
Cells were cultured and sub-cultured in preparation for apoptotic cell imaging (refer Section 
2.2 and 2.3). After the 5-day experimental protocol (refer Table 2.2) was completed, the 
medium from all the wells were removed using a vacuum pump and each well was washed 
with 300 µl of warm PBS. Thereafter, 300 µl of a 1:1 methanol/acetone fixative was added to 
each well and incubated for 10 minutes at 4°C. After 10 minutes the fixative was removed 
and wells left to air dry for 20 minutes. In the meantime a 5% donkey serum in PBS (5mL) 
stock solution was prepared to block non-specific binding sites, which was used in later steps 
of the staining procedure.  
After the wells had air dried, wells were washed with 300 µl PBS and 100 µl of Hoechst dye 
(Sigma, Steinheim, Germany) (1:200 dilution in PBS) added to each well. This was incubated 
for a further 10 minutes at room temperature in the dark. Thereafter, the contents in each well 
were removed, wells were washed twice with PBS, where after 300 µl PBS was added per 
well. The chambers were then wrapped in foil while transporting to the Olympus 
Biosystems™ Immunofluorescent Microscope (Olympus Biosystems, Germany) for imaging 
due to light sensitivity.  
The Olympus Cell^
R
 system is attached to a 1X-81 inverted fluorescence microscope 
(Olympus Biosystems, Germany) equipped with an F-view-II cooled CCD camera (Soft 
Imaging Systems, Germany). Using a Xenon-Arc burner (Olympus Biosystems GMBH) as a 
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light source, images were excited with the 360 nm, 472 nm or 572 nm excitation filter. 
Emission was collected using a UBG triple-bandpass emission filter cube.  
Each well was imaged individually using the 40x objective lens and Cell^
R 
imaging software. 
Each experiment was imaged independently, where four images per well were taken per 
condition, thus having a total number of 16 images per time point and 40 images per 
experiment. In each image there were 10-20 cells that were imaged, thus a total number of 
400-800 cells were imaged per experiment. Moreover, this experiment was repeated three 
times (independently).Each image was background subtracted and the number of apoptotic 
cells in each image was selected and the average number of apoptotic cells was calculated per 
condition, which was used for statistical analysis. Intensity signals that were more than 2x the 
standard deviation were omitted.  
Each experiment was analysed independently (n=3). Cells were counted as apoptotic based 
on nuclei condensation or fragmentation. The Hoechst (DAPI) filter was used, which was 
observed as a blue fluorescent staining of the cell nucleus, and employed a mechanism to 
assess cell death. 
 
2.6.3 Caspase-Glo 3 assay 
Cells were cultured for apoptotic cell analysis (refer Section 2.2 and 2.3). After the five day 
experimental protocol (refer Table 2.3) was completed, the medium in all the wells were 
discarded. The cells in each well were thereafter treated with 100 µl caspase assay reagent 
from the Caspase-Glo® 3/7 assay kit (Promega, Madison, WI) and incubated at room 
temperature for three hours. Thereafter the cells from each well were transferred to a white-
walled 96-well luminometer plate (Amersham, Buckinghamshire, UK).  
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The white wall 96-well plate was then analysed in a luminometer (Glomax, 96 Micoplate 
Luminometer™). The caspase activity in each well was analysed to provide an indication of 
the degree of apoptosis. The number of apoptotic cells was calculated by the software on the 
computer that was linked to the luminometer. 
The number of apoptotic cells were then used for statistical analysis. Intensity signals that 
were more than 2SD were omitted. Each experiment was analysed independently (n=3). 
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Day 
 
Experimental preparation: 96-well chambers 
 
1 
 
20,000 cells (20 µl) from the cell suspension (refer Section 2.3) were re-suspended in 
100 µl DMEM per well. Cells were incubated overnight at 37°C, 95% air and 5% CO2. 
 
2 
 
The medium was discarded to remove non-adherent cells and fresh medium was added 
to each well. Cells were subsequently incubated overnight before treatment. The control 
wells remained untreated. 
  
0.25 mM Oleic Acid (OA) 
 
40 µM DON 
 
40 µM DON + 0.25 mM 
OA 
 
3 
 
7.56 µl OA into “72 hr wells” 
 
No treatment 
 
7.56 µl OA into “72 hr 
wells” 
 
4 
 
7.56 µl OA into “48 hr wells” 
 
No treatment 
 
7.56 µl OA into “48 hr 
wells” 
 
5 
 
7.56 µl OA into “24 hr wells” 
 
No treatment 
 
7.56 µl OA into “24 hr 
wells” 
 
No treatment 
 
12 hrs prior to staining DON was administered where 
required (refer Appendix 2 for calculations) 
 
Table 2.3 Experimental design for the caspase 3 assay. 
 
Stellenbosch University http://scholar.sun.ac.za
43 
 
2.7 Data analysis 
Statistical analysis was performed using Graph Pad Prism 5. Results were expressed as a 
mean ± standard error of mean (SEM) of all experiments. Intergroup differences were 
analysed using non-parametric one-way analysis of variance (ANOVA) with the Newman-
Keuls Multiple Comparison test for column analyses. Values were considered to be 
significant at p<0.05. 
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Chapter 3: Results 
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3.1 H9c2 cell culture conditions 
H9c2 cardiomyoblasts were cultured in T25 culture flasks in low glucose medium and at 
three time intervals, i.e. 24, 48 and 72 hrs. Cells were also treated with oleic acid ± 6-diazo-5-
oxo-L-norleucine (DON) (GFAT inhibitor). DON treatments were initiated 12 hours prior to 
analysis and would be expected to reduce HBP flux. This experimental protocol was followed 
to assess the degree of oxidative stress, HBP activation (O-GlcNAcylation) and cell death 
(apoptosis and necrosis).  
 
3.2 Measurement of oxidative stress 
Cells were initially analysed on a flow cytometer to measure the degree of oxidative stress. 
No significant differences were found following oleic acid treatment, except at the 48 hr time 
interval, although this decrease was not significant (Figure 3.1).  
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3.2.1 Flow cytometry: H2DCF-DA staining 
 
 
 
 
 
 
 
 
 
 
Fig 3.1 Evaluating the effects of oleic acid treatment on the degree of oxidative stress (flow 
cytometry) 
H9c2 cardiomyoblasts were treated with 0.25 mM oleic acid for 24 hr, 48 hr and 72 hr, respectively. 
Cells were thereafter analysed on the flow cytometer to measure the degree of oxidative stress as 
described in the Materials and Methods section of this thesis (refer to section 2.4.1) – (n=3). 
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We next treated cells with an HBP inhibitor (DON) to determine the role of the HBP in this 
model under the same conditions. DON treatment decreased oxidative stress levels at 24 
hours to 67.2 ± 9.6% in comparison to the control and at 48 hours to 72.2 ± 11.0% in 
comparison to the control (n=3, p<0.05), but not at the 72 hour time interval (Figure 3.2). 
Additionally, the sole treatment of oleic acid at 48 hours decreased oxidative stress to 73.8 ± 
9.2% in comparison to the control, and the combined treatment of oleic acid and DON also 
decreased oxidative stress in the cells to 80.7 ± 4.9% in comparison to the control  at 48 hours 
(n=3, p<0.05). However, no additive effect was observed for oleic acid and DON treatment. 
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III. 
 
 
 
 
 
 
 
 
 
Fig 3.2 The effect of oleic acid treatment ± HBP inhibition on oxidative stress (flow cytometry) 
H9c2 cells were treated with oleic acid ± DON for 24 hr (I), 48 hr (II) and 72 hr (III), respectively. 
Subsequently, cells were analysed on the flow cytometer to measure the degree of oxidative stress as 
described earlier (refer to section 2.4.1 of the Materials and Methods section of this thesis). * p<0.05 
versus control. Values are expressed as mean ± SEM - (n=3). 
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3.2.2 Immunofluorescence microscopy: H2DCF-DA staining 
To further confirm these findings we evaluated cells by immunofluorescence imaging. 
However, we found no significant changes with oleic acid treatment (Figure 3.3). 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.3 Evaluating the effects of oleic acid treatment on the degree of oxidative stress 
(immunofluorescence microscopy) 
H9c2 cardiomyoblasts were treated with 0.25 mM oleic acid for 24 hr, 48 hr and 72 hr, respectively. 
Cells were analysed using immunofluorescence imaging to measure the degree of oxidative stress as 
described earlier (refer to section 2.4.2 of the Materials and Methods section of this thesis). – (n=3). 
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To assess the role of the HBP, we included DON in our experiment protocol. HBP inhibition 
decreased oxidative stress at the 24 and 48 hour time points (Figures 3.4 and 3.5). At the 24 
hour time point DON treatment decreased oxidative stress by .57.4 ± 20.1% in comparison to 
DON + oleic acid (n=3, p<0.05). At 48 hours DON treatment decreased oxidative stress by 
65.9 ± 2.9% in comparison to the control, and DON + oleic acid treatment decreased 
oxidative stress by 73.5 ± 5.9% in comparison to the control (n=3, p<0.005). 
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III.  
 
 
 
 
 
 
 
 
 
Fig 3.4 The effect of oleic acid treatment ± HBP inhibition on oxidative stress 
(immunofluorescence microscopy) 
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr (I), 48 hr (II) and 72 hr (III), 
respectively. Cells were analysed using immunofluorescence imaging to measure the degree of 
oxidative stress as described earlier (refer to section 2.4.2 of the Materials and Methods section of this 
thesis). ** p<0.005 versus control and # p<0.05 versus DON + oleic acid. Values are expressed as 
mean ± SEM – (n=3). 
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Control 
 
Oleic acid 
 
  
 
HBP inhibitor (DON) 
 
Oleic acid + HBP inhibitor (DON) 
 
 
Fig 3.5 The effect of oleic acid treatment ± HBP inhibition on oxidative stress 
(immunofluorescence microscopy) 
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr, 48 hr and 72 hr, respectively. 
Cells were analysed using immunofluorescence imaging to measure the degree of oxidative stress as 
described earlier (refer to section 2.4.2 of the Materials and Methods section of this thesis). Cells were 
viewed at 100x magnification under an immunofluorescence microscope. The nucleus was stained 
with Hoechst (blue) stain and the rest of the cell stained green (H2DCF-DA), which is an indication of 
overall ROS production. Representative images were chosen from all time points to depict what is 
represented in the bar graphs (Fig 3.4) – (n=3). 
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3.3 Evaluating the level of O-GlcNAcylation: an indication of HBP flux 
To evaluate HBP flux we employed a flow cyometric method to determine the degree of O-
GlcNAcylation. The data show that O-GlcNAcylation increased, although this was not 
significant (Figure 3.6). 
 
3.3.1 Flow cytometry 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.6 Determining the effects of oleic acid treatment on HBP activation (flow cytometry) 
H9c2 cardiomyoblasts were treated with 0.25 mM oleic acid for 24 hr, 48 hr and 72 hr, respectively. 
Cells were analysed using flow cytometry to evaluate the level of overall O-GlcNAcylation as 
described earlier (refer to section 2.5.1 of the Materials and Methods section of this thesis). - (n=3). 
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Based on these findings, we decided to assess the role of the HBP at the same time intervals, 
but exposed to oleic and/or DON treatment to determine if it was able to diminish oleic acid-
induced O-GlcNAcylation (Figure 3.7); supporting our data that oleic acid definitely activates 
the HBP in H9c2 cardiomyoblasts. This was particularly observed at 48 hours by 168.2 ± 
15.5% in comparison to the control (n=3, p<0.005) as well as at 72 hours by 163.7 ± 29.8% 
in comparison to the control (n=3, p<0.05). However, DON treatment inhibited HBP 
activation at 24 hours by 88.7 ± 4.1%; 48 hours by 119.3 ± 8.0% and at 72 hours by 86.1% ± 
6.3% in comparison to oleic acid (n=3, p<0.05). Additionally, DON + oleic acid treatment 
decreased levels of O-GlcNAcylation at 72 hours by 87.5 ± 4.8% in comparison to oleic acid 
(n=3, p<0.05). 
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III. 
 
 
 
 
 
 
 
 
 
Fig 3.7 The effect of oleic acid treatment ± HBP inhibition on O-GlcNAcylation (flow cytometry) 
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr (I), 48 hr (II) and 72 hr (III), 
respectively. Cells were analysed using flow cytometry to evaluate the level of overall O-
GlcNAcylation as described earlier (refer to section 2.5.1 of the Materials and Methods section of this 
thesis). * p<0.05 versus control, ** p<0.005 versus control, # p<0.05 versus oleic acid. Values are 
expressed as mean ± SEM - (n=3). 
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3.3.2 Immunofluorescence microscopy 
Immunofluorescence imaging evaluated overall O-GlcNAcylation but, we found no 
significant changes with oleic acid treatment using this method (Figure 3.8). 
 
 
 
 
 
 
 
 
 
 
Fig.3.8 The effect of oleic acid on HBP flux (immunofluorescence microscopy) 
H9c2 cardiomyoblasts were treated with 0.25 mM oleic acid 24 hr, 48 hr and 72 hr, respectively. Cells 
were viewed under the immunofluorescence microscopy to evaluate overall O-GlcNAcylation, as 
described in the Materials and Methods section of this thesis (refer to section 2.5.2) - (n=3). 
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The same trend was found after DON treatment with no significant changes (Figures 3.9 and 
3.10). 
I. 
 
 
 
 
 
 
 
 
 
 
II. 
 
 
 
 
 
 
 
 
 
 
 
 
Control Oleic acid DON DON + Oleic acid
0
50
100
150
F
lu
o
re
sc
en
ce
 i
n
te
n
si
ty
(A
rb
it
ra
ry
 u
n
it
s)
Control Oleic acid DON DON + Oleic acid 
0
50
100
150
F
lu
or
es
ce
nc
e 
in
te
ns
it
y
(A
rb
it
ra
ry
 u
ni
ts
)
Stellenbosch University http://scholar.sun.ac.za
58 
 
III. 
 
 
 
 
 
 
 
 
 
Fig 3.9 The effect of oleic acid treatment ± HBP inhibitor on HBP flux (immunofluorescence 
microscopy) 
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr (I), 48 hr (II) and 72 hr (III), 
respectively. The cells were viewed using immunofluorescence imaging to evaluate overall O-
GlcNAcylation, as described in the Materials and Methods section of this thesis (refer to section 
2.5.1) - (n=3). 
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Fig 3.10 The effect of oleic acid treatment ± HBP inhibitor on HBP flux (immunofluorescence 
microscopy) 
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr, 48 hr and 72 hr, respectively. 
The cells were viewed using immunofluorescence imaging to evaluate overall O-GlcNAcylation, as 
described in the Materials and Methods section of this thesis (refer to section 2.5.1). Cells were 
viewed at 100x magnification under an immunofluorescence microscope. The nucleus was stained 
with Hoechst (blue) stain and the rest of the cell stained red (Texas Red), which is an indication of 
overall O-GlcNAcylation. Representative images were chosen from all time points to depict what is 
represented in the bar graphs (Fig. 3.9) - (n=3). 
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3.4 Assessment of apoptosis 
To evaluate the effects of oleic acid on cell death, i.e. apoptosis and necrosis it was found that 
oleic acid treatment markedly reduced apoptotic cell death as assessed by flow cytomery 
(Figure 3.11). Apoptosis was attenuated at 24 hours by 0.7 ± 0.2% ; 48 hours by 1.1 ± 0.3% 
and at 72 hours by 1.0 ± 0.2% in comparison to the control [ 4.7 ± 1.3% (n=3, p<0.005)]. 
3.4.1 Flow cytometry: Propidium iodide & Annexin V staining 
 
 
 
 
 
 
 
 
 
Fig 3.11 Evaluating the anti-apoptotic effects of oleic acid (flow cytometry) 
H9c2 cardiomyoblasts were treated with 0.25 mM oleic acid for 24 hr, 48 hr and 72 hr, respectively. 
The cells were analysed using flow cytometry to assess apoptosis as described in the Materials and 
Methods section of this thesis (refer to section 2.6.1). ** p<0.005 versus control. Values are expressed 
as mean ± SEM - (n=3). 
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We subsequently tested the role of the HBP within this context. Oleic acid treatment resulted 
in an anti-apoptotic phenotype as before (Figure 3.12). This concept was observed at 24 hours 
where oleic acid decreased apoptosis by 1.2 ± 0.6% in comparison to the control [4.7 ± 1.3% 
(n=3, p<0.005)], as well as at 72 hours by 1.0 ± 0.2% in comparison to the control [4.7 ± 
1.3% (n=3, p<0.05)]. However, DON had an even greater anti-apoptotic effect. DON 
treatment also further decreased the anti-apoptotic effects of oleic acid (Figure 3.12). DON 
decreased apoptosis at 24 hours by 0.7 ± 0.3% as well as at 72 hours by 0.9 ± 0.2% in 
comparison to the control [4.7 ± 1.3% (n=3, p<0.05)]. Additionally, an additive effect was 
observed when the cardiomyoblasts were treated with DON and oleic acid. The combined 
treatment decreased apoptosis at 24 hours by 0.6 ± 0.1% in comparison to the control [4.7 ± 
1.3% (n=3, p<0.05)]., and at 72 hours by 0.6 ± 0.2% in comparison to the control [4.7 ± 1.3% 
(n=3, p<0.005)]. At the 48 hour time point there was also a downward trend observed with 
regard to apoptosis, although this was not significant. 
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II. 
 
 
 
 
 
 
 
 
 
III. 
 
 
 
 
 
 
 
 
 
 
Fig 3.12 Evaluating the anti-apoptotic effects of HBP inhibition (flow cytometry) 
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr (I), 48 hr (II) and 72 hr (III), 
respectively. Cells were analysed using flow cytometry to assess apoptosis as described in the 
Materials and Methods section of this thesis (refer to section 2.6.1). * p<0.05 versus control,     
** p<0.005 versus control. Values expressed as mean ±  SEM - (n=3). 
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3.4.2 Immunofluorescence microscopy: Hoechst staining 
To establish repeatability and validity the protocol was repeated using immunofluorescence 
microscopy to view the apoptotic nuclei. We found no significant changes when using this 
technique (Figure 3.13). 
I. 
 
 
 
 
 
 
  
 
 
Fig 3.13 The anti-apoptotic effects of oleic acid (immunofluorescence microscopy) 
H9c2 cardiomyoblasts were treated with 0.25 mM oleic acid for 24 hr, 48 hr and 72 hr, respectively. 
The cells were analysed using immunofluorescence imaging to assess apoptosis as described in the 
Materials and Methods section of this thesis (refer to section 2.6.2). - (n=3). 
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We next evaluated the role of the HBP when the cells were exposed to oleic acid and/or 
DON. The data shows, a downward trend in apoptosis mainly at the 72 hour time point, 
although this was not a significant change (Figures 3.14 and 3.15). 
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III. 
 
 
 
 
 
 
 
 
Fig 3.14 The anti-apoptotic effects of HBP inhibition (immunofluorescence microscopy)  
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr (I), 48 hr (II) and 72 hr (III), 
respectively. Cells were viewed using immunofluorescence microscopy to assess apoptosis as 
described in the Materials and Methods section of this thesis (refer to section 2.6.2) - (n=3). 
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Fig. 3.15 The anti-apoptotic effects of HBP inhibition (immunofluorescence microscopy)  
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr, 48 hr and 72 hr, respectively. 
Cells were viewed using immunofluorescence microscopy to assess apoptosis as described in the 
Materials and Methods section of this thesis (refer to section 2.6.2). Cells were viewed at 40x 
magnification under an immunofluorescence microscope. The nucleus was stained with Hoechst 
(blue) stain to identify apoptotic nuclei. Yellow arrows indicate apoptotic nuclei that are either 
condensed or fragmented of which there were only a few apoptotic cells, hence, there being no 
significant differences between treatment groups as depicted in the bar graphs (Fig. 3.14). 
Representative images were chosen from all time points to depict what is represented in the bar 
graphs - (n=3). 
 
Stellenbosch University http://scholar.sun.ac.za
67 
 
3.5 Caspase-Glo 3 assay 
To confirm our apoptosis data obtained by flow cytometry and immunofluorescence 
microscope imaging, we also assessed apoptosis by using a luminescence-based caspase 
assay. Our data confirmed that oleic acid treatment results in anti-apoptotic effects, although 
the changes were not significant (Figure 3.16). 
III. 
 
 
 
 
 
 
 
 
Fig 3.16 Evaluating the anti-apoptotic effects oleic acid (caspase assay)  
H9c2 cardiomyoblasts were treated with 0.25 mM oleic acid for 24 hr, 48 hr and 72 hr, respectively. 
Cells were analysed using luminescence to assess apoptosis as described in the Materials and Methods 
section of this thesis (refer to section 2.6.3). - (n=3). RLU: Relative Luciferase Units. 
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To evaluate the role of the HBP, we treated cells with DON and found (as before) that it 
decreased apoptosis (Figure 3.17). At 24 hours there was a downward trend in apoptosis, 
although this was not significant decreases. At 48 hours however, oleic acid attenuated 
apoptosis by 25614 ± 3171% in comparison to the control [42379 ± 5064% (n=3, p<0.05)]. 
However, DON inhibited the effects of the HBP, and like oleic acid, also showed anti-
apoptotic effects at 48 hours where apoptosis was decreased by 17391 ± 1938% in comparison 
to the control [42379 ± 5064% (n=3, p<0.005)], as well as at 72 hours where DON decreased 
apoptosis by 13116 ± 189.2% in comparison to the control [42379 ± 5064% (n=3, p<0.005)], and by 
13116 ± 189.2% in comparison to oleic acid [31235 ± 7300% (n=3, p<0.05)]. However, co-treatment 
with DON and oleic acid did not further decrease the anti-apoptotic effects of sole oleic acid 
treatment, although it did decrease apoptosis at 48 hours by 29484 ± 3818% in comparison to 
the control [42379 ± 5064% (n=3, p<0.05)], and at 72 hours by 12838 ± 1356% in comparison to the 
control [42379 ± 5064% (n=3, p<0.005)], and by 12838 ± 1356% in comparison to oleic acid [31235 
± 7300% (n=3, p<0.05)], 
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II. 
 
 
 
 
 
 
 
 
 
III. 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.17 Evaluating the anti-apoptotic effects of the HBP inhibitor (Caspase assay).  
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr (I), 48 hr (II) and 72 hr (III), 
respectively. The cells were analysed using luminescence to assess apoptosis as described in the 
Materials and Methods section of this thesis (refer to section 2.6.3). * p<0.05 versus control,             
** p<0.005 versus control, # p<0.05 versus oleic acid, Values are expressed as mean ± SEM - (n=3). 
RLU: Relative Luciferase Units. 
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3.6 Assessment of necrosis 
We also evaluated the effects of oleic acid treatment on necrosis (by flow cytometry). Our 
data show that oleic acid treatment decreased necrotic cell death after 48 hours of treatment 
(Figure 3.18). Oleic acid decreased necrosis at 48 hours by 1.0 ± 0.2% in comparison to the 
control [1.6 ± 0.2% (n=3, p<0.05)], and by 1.0 ± 0.2% in comparison to both 24 hours [1.8 ± 0.2% 
(n=3, p<0.05)] and 72 hours [2.0 ± 0.1% (n=3, p<0.05)]. 
 
3.6.1 Flow cytometry: Propidium iodide & Annexin V staining 
 
I. 
 
 
 
 
 
 
 
 
Fig 3.18 Evaluating the anti-necrotic effects of oleic acid (flow cytometry) 
H9c2 cardiomyoblasts were treated with 0.25 mM oleic acid for 24 hr, 48 hr and 72 hr, respectively. 
The cells were analysed using flow cytometry to assess necrosis as described in the Materials and 
Methods section of this thesis (refer to section 2.6.1).* p<0.05 versus control, # p<0.05 versus oleic 
acid 24 hr and 72 hr. Values are expressed as mean ± SEM - (n=3). 
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Sole DON treatment also resulted in robust anti-necrotic effects (Figure 3.19), whereby DON 
decreased necrosis at 24 hours by 1.1 ± 0.2% in comparison to oleic acid [1.8 ± 0.2% (n=3, 
p<0.05)], and at 72 hours by 1.0 ± 0.2% in comparison to oleic acid [2.0 ± 0.1% (n=3, p<0.05)]. 
When the cardiomyoblasts were treated with DON + oleic acid, a decrease in necrosis was noted at 24 
hours by 1.0 ± 0.2% in comparison to oleic acid [1.8 ± 0.2% (n=3, p<0.05)], although this was not an 
additive effect in comparison to the sole treatment of oleic acid and DON. Additionally, a downward 
trend in necrosis was noted at 48 hours, but it was not a significant trend. 
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III. 
 
 
 
 
 
 
 
 
 
 
Fig 3.19 Evaluating the anti-necrotic effects of HBP inhibition (flow cytometry) 
H9c2 cardiomyoblasts were treated with oleic acid ± DON for 24 hr (I), 48 hr (II) and 72 hr (III), 
respectively. The cells were analysed using flow cytometry to assess necrosis as described in the 
Materials and Methods section of this thesis (refer to section 2.6.1). # p<0.05 versus oleic acid. Values 
are expressed as mean ± SEM - (n=3). 
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Chapter 4: Discussion 
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4.1 Introduction 
Obesity and type 2 diabetes are two common pre-disposing factors for cardiovascular disease; 
it has been estimated that the prevalence of obesity will increase to ~1.35 billion by 2030 [6]. 
There are, however, a number of factors that play a role in individuals becoming obese and 
unhealthy, but for the present study, we focused on increased fatty acid supply and its impact 
on the HBP and cell death.  
Here we ventured in the opposite direction and investigated whether oleic acid acts as a novel 
cardioprotective agent. We further examined whether this effect occurred via the HBP. The 
key findings of this study are: 1) Oleic acid blunts oxidative stress and cell death (apoptosis 
and necrosis) in H9c2 cells; 2) Oleic acid activates the HBP; and 3) There is no cross-talk 
between HBP activation and oleic acid-mediated reduction of oxidative stress and cell death. 
 
4.2 Oleic acid blunts oxidative stress and cell death in H9c2 cardiomyoblasts 
We initially tested whether oleic acid acts as an anti-oxidant. The flow cytometry data show 
that oxidative stress was significantly decreased after 48 hours of treatment. The data 
therefore indicate a peak response at the 48 hour time point. We propose that this may be due 
to the time necessary to initiate downstream effects (e.g. composition of biological 
membranes and activation of transcriptional mechanisms) that are later discussed. We largely 
confirmed flow cytometric data by employing immunofluorescent microscopy, where slight 
changes was observed between treatments. 
How does oleic acid reduce oxidative stress? We have been unable to pursue this question in 
the present study, but wish to make several proposals (based on the literature) of how this 
may transpire. 
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In the first instance, it is likely that this may occur by protecting biological membranes, e.g. 
the sarcolemma and mitochondrial membrane. The degree of saturation of membranes 
increases the sensitivity to lipid peroxidation, i.e. increased number of double bonds per 
molecule and a greater number of unstable electrons. De Vries et al. (1997) [2] found that in 
response to oleic acid exposure, neonatal cardiomyocytes increased the percentage of mono-
unsaturated fatty acids in the phospholipid pool by approximately 3-fold [16]. Thus, the 
supply of a monounsaturated fatty acid like oleic acid may increase the degree of unsaturation 
and thereby attenuate intracellular oxidative stress. In agreement, others [12] found that 
consumption of virgin olive oil lowered peroxidation in liver mitochondria and microsomes. 
Here the concept proposed is that the type of dietary fat affects biological membrane 
function, e.g. mitochondrial membranes and their susceptibility to oxidative stress [5, 10, 12-
13]. 
 
Another possible mechanism that may explain our findings is the proposal that oleic acid may 
increase intracellular anti-oxidant capacity. Rats fed palm olein oil (rich in oleic acid; 42.7 – 
43.9%) [3, 8-9] displayed elevated myocardial catalase, superoxide dismutase and glutathione 
peroxidase activities [8]. This was associated with increased protection of hearts in response 
to ischemia-reperfusion damage. Thus, we propose that oleic acid may exert its anti-oxidant 
effects by enhancing biological membrane function(s) and/or by increasing intracellular anti-
oxidant capacity. These interesting possibilities require further investigations in our 
experimental system.  
 
 
Stellenbosch University http://scholar.sun.ac.za
76 
 
Testing whether oleic acid administration was able to inhibit cell death in H9c2 
cardiomyoblasts we found that oleic acid decreased apoptosis at all three time points (flow 
cytometry). When DON was administered to these cells, apoptosis was also decreased, and 
with a combination treatment of DON + oleic acid, and additive effect was observed at 24 
and 72 hours. These data was also confirmed by a caspase activity analysis and 
immunofluorescent microscopy. In the caspase assay apoptosis was significantly decreased at 
48 hours, but it was not significantly decreased at 24 hours. At 72 hours the DON and DON + 
oleic acid treatment decreased apoptosis. For immunofluorescence microscopy, a downward 
trend in apoptosis was observed, although this was not significant. Moreover, our data show 
that oleic acid treatment also inhibited necrosis, particularly at 48 hours. 
 
It is unclear whether oleic acid directly affects apoptosis and necrosis pathways, or whether 
these effects occur secondarily to the reduction in oxidative stress. Since oxidative stress 
plays a key role in triggering both apoptosis and necrosis pathways [14, 15] it is likely that 
this scenario may hold in this experimental model. However, further studies are required to 
confirm this, e.g. we are planning to include an anti-oxidant in our experimental system and 
then test its effect on apoptosis and necrosis, respectively. 
 
It is also possible that there may be direct effects (i.e. not related to decreased oxidative 
stress) mediated by oleic acid found that upregulated PI3K is upregulated an anti-apoptotic 
factor, in cultured breast cancer cells [4]. PI3K activation enhances cell survival and blunts 
apoptosis via its downstream target, Akt /PKB [3, 11]. Moreover, elevated monounsaturated 
fatty acids in the phospholipid pool may increase membrane fluidity and thereby decrease 
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apoptosis [2, 16]. Here the idea is put forward that alterations in the composition of 
phospholipid membranes may act as a trigger for apoptosis [17], e.g. increased saturated fatty 
acids may impair membrane fluidity and increase apoptosis [16]. 
A further possibility is that oleic acid may have transcriptional effects in the nucleus. 
Previous research has shown that oleic acid upregulated Bcl-2 levels in pancreatic β-cells and 
thereby protected against saturated fat-mediated apoptosis. Increased Bcl-2 availability will 
be expected to inhibit cytochrome-c release from the mitochondrion and thereby limit the 
apoptotic cascade [7]. Oleic acid may facilitate triglyceride accumulation (inert) in non-
adipocytes and thereby decrease lipotoxic effects of „active‟ lipid derivatives, e.g. ceramide-
mediated apoptosis [2]. These possibilities require further investigation in our protocol. 
 
4.3 Oleic acid activates the HBP 
A novel finding, as far as we are aware, is that oleic acid increased the overall O-
GlcNAcylation (by flow cytometric analysis) at 48 and 72 hours, suggesting increased HBP 
flux. However, we were unable to confirm these findings by immunofluorescent microscopy. 
Furthermore, we feel confident about our flow cytometric data since we typically screened 
5,000 cells while the selection of representative cells (immunofluorescent microscopy) was 
difficult at times.  
How does oleic acid activate the HBP? We propose that this may occur via the Randle effect 
in which higher fatty acid oxidation rates lead to PDH and PFK inhibition (refer to Fig 1.2 in 
the Introduction).  
Subsequently, there may be an accumulation of upstream metabolites that could enter the 
HBP and result in increased O-GlcNAcylation as found in our research. Acetyl-CoA 
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produced from increased fatty acid oxidation can also enter the HBP, i.e. required for the 
correction of glucosamine-6-phosphate to GlcNAc-6-phosphate. 
 
4.4 No cross-talk between HBP activation and oleic acid-mediated reduction of oxidative 
stress and cell death 
The data show that oleic acid treatment triggers distinct cardioprotective pathways and that 
this does not occur solely via HBP activation. We also found that HBP inhibition (using 
DON) resulted in decreased oxidative stress and attenuated cell death (apoptosis and 
necrosis). However, when oleic acid and HBP inhibition were combined, no additive effects 
were observed in terms of downstream effects, i.e. degree of oxidative stress and cell death.  
Figure 4.1 shows several possible scenarios that may occur. Since we found oleic acid 
increases the HBP, there are two possible outcomes, i.e. pathway #1 (increased ROS, 
increased cell death) versus pathway #2 (decreased ROS, decreased cell death). 
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Fig 4.1 Interrelationship between oleic acid and the HBP? 
Previous studies found that increased HBP flux may have detrimental or protective effects [1; 
14, 15]. Essop et al. (2010) found that higher flux through the HBP caused increased 
oxidative stress and cell death (apoptosis) [14, 15]. This was shown to occur by increased 
BAD-O-GlcNAcylation and greater BAD-Bcl2 dimerization.  
We proposed increased BAD-Bcl2 dimerization, thus causing less Bax-Bcl2 dimerization, 
greater Bax-Bax dimerization and increased apoptosis. 
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However, Chatham et al. (2010) found that increased O-GlcNAcylation contributed to 
ischemic cardioprotection [1]. An increased O-GlcNAylation augmented heat shock protein 
synthesis (HSP40 and HSP70), both O-GlcNAc modified. Increased O-GlcNAcylation of 
transcription factor, Sp1, may contribute to the synthesis of heat shock proteins and the pro-
survival of Bcl2 family members. Increased O-GlcNAc levels also cause an increase in p38 
phosphorylation.  
 
Although p38 is considered to be pro-apoptotic, it can also activate pro-survival pathways 
through downstream effectors, such as αB-crystallin and HSP27, which both play a role in 
ischemic protection and are targets of O-GlcNAc modification. We believe that our data 
suggest that pathway #2 (Figure 4.1) is less likely since no additive effects were noted when 
DON and oleic acid (OA) were combined. Thus, we propose that OA activates the HBP and 
likely turns on pathway #1 but that this does not form a major part of its action(s).  
 
More likely, it appears to strongly activate pathway #3 to diminish oxidative stress and cell 
death. Here, cell death may either occur secondarily to the reduction in oxidative stress and/or 
via direct means, e.g. increased activation of PI3K and/or PKC (Figure 4.1). Increased Bcl2 
levels may also contribute to its cardioprotective effects.  
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4.5 Conclusion 
This study explored whether a monounsaturated fatty acid, oleic acid, is able to act as a novel 
cardioprotective agent. Our in vitro data supports this concept and here we show that it is able 
to blunt oxidative stress and cell death. Moreover, we found that although oleic acid activates 
the HBP, it does not mediate its protective effects via this pathway alone. Although this study 
was performed under normoxic conditions, apoptosis is a procedure of programmed cell 
death that occurs, therefore even though this study was performed under unstressed 
conditions, the apoptotic data in particular, can be accepted as being statistically and 
physiologically correct. Moreover, it is part of our future plans to test the efficacy of oleic 
acid under stressed conditions, e.g. hyperglycemia and/or increased oxidative stress. 
Therefore further studies in animals and humans are required to confirm our interesting data 
and to eventually translate this into clinical benefit to patients suffering from diabetes and 
heart diseases. 
 
4.6 Limitations 
It is possible that the technical problems contributed to the lack of changes observed and that 
our microscopy method requires further optimization. However, the immunoflourescence 
microscopy data was based on a rather subjective opinion, because the cells that were 
selected for imaging were the cells that I thought were most representative of the parameter 
being assessed. For example, in the immunofluorescence microscopy technique, after the four 
images were taken per well per condition, these images were background subtracted, in order 
to lessen the amount of fluorescent intensity in the background in order to better view the 
cells. In my opinion this was unfortunate because in most cases the actual „true‟ fluorescence 
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of the cells were lost, because the level of background subtraction (4 units particularly for my 
images) had to be maintained for all images, for the purpose of being standard throughout an 
experiment. In my opinion this led to an under representation of what the fluorescence 
intensity of the target molecule really was. In cases of the fluorescence intensity already 
being low, these images in particular were compromised when they were background 
subtracted. 
In my opinion this was the reason for the discrepancy in data when comparing flow 
cytometry to immunofluorescence microscopy. I do not believe that this had anything to do 
with my statistical analysis being based on a n=3, since ~60,000 cells were analysed using the 
flow cytometry technique and 400-800 cells were analysed using immunofluorescence 
microscopy. Additionally, an n=3 has been used in other publications as well using the same 
techniques to evaluate certain parameters using H9c2 cells as a experimental model [1, 2]. 
Another parameter that could also have played a role was the fact that only a single 
concentration of oleic acid was tested in this study.  Our rationale for selecting this particular 
dosage was based on a previous study that was done using similar techniques, but employing 
a slightly different experimental model [3].  Thus future work should include a dose-
dependent analysis to more fully characterize the effects of oleic acid in our experimental 
system. 
Of note, the term “oxidative stress” was used in a rather loose fashion in this thesis write-up. 
However, to fully confirm whether this indeed represents „‟oxidative stress‟‟, our 
experimental system should be challenged with varying doses of oleic acid as described 
above.  This is likely to form part of our future studies. 
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4.7 Future research direction 
In order to determine which pathways are involved in the contribution to the beneficial 
effects of OA in our experimental system we intend to test for OA ± Wortmannin (inhibitor 
of PI3K) and also OA ± chelerythrine (PKC inhibitor) and if these pathways are blunted and 
the beneficial effects are lost, this will confirm whether our proposals are indeed correct. 
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